HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 283, Issue 8, 5069-5080, February 22, 2008

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 283/8/5069    most recent M708734200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ouellet, H. Articles by de Montellano, P. R. O. Search for Related Content PubMed PubMed Citation Articles by Ouellet, H. Articles by de Montellano, P. R. O. Social Bookmarking                      What's this?

Mycobacterium tuberculosis CYP130

CRYSTAL STRUCTURE, BIOPHYSICAL CHARACTERIZATION, AND INTERACTIONS WITH ANTIFUNGAL AZOLE DRUGS^*

From the Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158

CYP130 is one of the 20 Mycobacterium tuberculosis cytochrome P450 enzymes, only two of which, CYP51 and CYP121, have so far been studied as individually expressed proteins. Here we characterize a third heterologously expressed M. tuberculosis cytochrome P450, CYP130, by UV-visible spectroscopy, isothermal titration calorimetry, and x-ray crystallography, including determination of the crystal structures of ligand-free and econazole-bound CYP130 at a resolution of 1.46 and 3.0Å_, respectively. Ligand-free CYP130 crystallizes in an "open" conformation as a monomer, whereas the econazole-bound form crystallizes in a "closed" conformation as a dimer. Conformational changes enabling the "open-closed" transition involve repositioning of the BC-loop and the F and G helices that envelop the inhibitor in the binding site and reshape the protein surface. Crystal structure analysis shows that the portion of the BC-loop relocates as much as 18Å between the open and closed conformations. Binding of econazole to CYP130 involves a conformational change and is mediated by both a set of hydrophobic interactions with amino acid residues in the active site and coordination of the heme iron. CYP130 also binds miconazole with virtually the same binding affinity as econazole and clotrimazole and ketoconazole with somewhat lower affinities, which makes it a plausible target for this class of therapeutic drugs. Overall, binding of the azole inhibitors is a sequential two-step, entropy-driven endothermic process. Binding of econazole and clotrimazole exhibits positive cooperativity that may reflect a propensity of CYP130 to associate into a dimeric structure.

Received for publication, October 22, 2007 , and in revised form, November 28, 2007.

The atomic coordinates and structure factors (code 2UUQ and 2UVN) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

^* This work was supported by National Institutes of Health RO1 Grants GM25515, AI74824 (to P. O. M.), and GM078553 (to L. M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S3.

¹ To whom correspondence should be addressed: Dept. of Pharmaceutical Chemistry, 600 16th St., N572D, San Francisco, CA 94158. Tel.: 415-476-2903; E-mail: ortiz{at}cgl.ucsf.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. G. S. Warrilow, C. J. Jackson, J. E. Parker, T. H. Marczylo, D. E. Kelly, D. C. Lamb, and S. L. Kelly Identification, Characterization, and Azole-Binding Properties of Mycobacterium smegmatis CYP164A2, a Homolog of ML2088, the Sole Cytochrome P450 Gene of Mycobacterium leprae Antimicrob. Agents Chemother., March 1, 2009; 53(3): 1157 - 1164. [Abstract] [Full Text] [PDF]

				K. J. McLean, P. Carroll, D. G. Lewis, A. J. Dunford, H. E. Seward, R. Neeli, M. R. Cheesman, L. Marsollier, P. Douglas, W. E. Smith, et al. Characterization of Active Site Structure in CYP121: A CYTOCHROME P450 ESSENTIAL FOR VIABILITY OF MYCOBACTERIUM TUBERCULOSIS H37Rv J. Biol. Chem., November 28, 2008; 283(48): 33406 - 33416. [Abstract] [Full Text] [PDF]

				N. R. Melo, G. P. Moran, A. G. S. Warrilow, E. Dudley, S. N. Smith, D. J. Sullivan, D. C. Lamb, D. E. Kelly, D. C. Coleman, and S. L. Kelly CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility Antimicrob. Agents Chemother., October 1, 2008; 52(10): 3718 - 3724. [Abstract] [Full Text] [PDF]